Display Settings:

Items per page
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 7

1.
Figure 6

Figure 6. From: Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.

Loss of bone marrow osteoblasts is associated with cytokine-induced mobilization. Mice (n = 4-6 each group) were treated with G-CSF, Flt3L, or SCF for 7 days. Bone marrow osteoblasts were enumerated in H&E-stained paraffin sections using standard histomorphometric technique. Shown is the percentage of osteoblast-covered bone surface (A) and number of osteoblasts per bone perimeter (B). Data represent mean ± SEM; *P < .05.

Matthew J. Christopher, et al. Blood. 2009 August 13;114(7):1331-1339.
2.
Figure 1

Figure 1. From: Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.

G-CSF treatment does not increase the number of circulating progenitors in CXCR4−/− chimeras. Wild-type (CXCR4+/+) and CXCR4−/− chimeras (n = 7-10 each group) were treated with G-CSF or left untreated (control), and CFU-Cs were measured in (A) peripheral blood, (B) spleen, and (C) bone marrow. Data represent mean ± SEM of pooled data from 2 separate experiments; *P < .01.

Matthew J. Christopher, et al. Blood. 2009 August 13;114(7):1331-1339.
3.
Figure 2

Figure 2. From: Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.

Bone marrow metalloproteinases and neutrophil elastase are induced normally in CXCR4−/− chimeras. Bone marrow chimeras (n = 2-4 each group) reconstituted with wild-type (CXCR4+/+) or CXCR4−/− fetal liver cells were treated with G-CSF or left untreated (ctrl) and bone marrow plasma was isolated. Metalloproteinase (A) and neutrophil elastase (B) activity in the bone marrow plasma was estimated by measuring cleavage of labeled substrate and normalizing for protein content. Data represent mean ± SEM; *P < .05; **P < .01.

Matthew J. Christopher, et al. Blood. 2009 August 13;114(7):1331-1339.
4.
Figure 3

Figure 3. From: Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.

VLA-4 antagonism increases number of circulating HSPCs in CXCR4+/+ and CXCR4−/− chimeras. CXCR4+/+ and CXCR4−/− chimeras (n = 6-9 each group) were treated with BIO5192, a specific VLA-4 antagonist, and peripheral blood CFU-Cs were measured in (A) CXCR4+/+ and (B) CXCR4−/− chimeras. (C) Recipient mice (n = 3 each group) were administered VLA-4 inhibitor or vehicle 3 hours before adoptive transfer of 6 × 106 wild-type bone marrow mononuclear cells. The number of circulating CFU-Cs was measured before adoptive transfer (t = 0) and 2 and 30 minutes after adoptive transfer. Data represent mean ± SEM; *P < .01.

Matthew J. Christopher, et al. Blood. 2009 August 13;114(7):1331-1339.
5.
Figure 4

Figure 4. From: Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.

Groβ administration decreases the number of circulating HSPCs in CXCR4−/− chimeras. Circulating CFU-Cs were measured in CXCR4+/+ (A, n = 3-6) and CXCR4−/− (B, n = 5-11) chimeras at the indicated time points after administration of Groβ (2.5 mg/kg). (C) CXCR4+/+ (WT) or CXCR4−/− (KO) chimeras (n = 3-4 each group) were treated with Groβ or left untreated (ctrl). Serum was collected 15 minutes after treatment and assayed for metalloproteinase activity. (D) Wild-type mice (n = 4 each group) were given a single injection of AMD3100 (5 mg/kg) and 3 hours later Groβ was administered. Shown is number of circulating CFU-Cs before and 15 minutes after Groβ administration. Data represent mean ± SEM; *P < .05 compared with pretreatment; **P < .01 vs control.

Matthew J. Christopher, et al. Blood. 2009 August 13;114(7):1331-1339.
6.
Figure 7

Figure 7. From: Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.

Cytokine-induced mobilization results in the specific loss of osteoblast CXCL12 expression. (A) Representative photomicrograph of CXCL12 RNA in situ from G-CSF–treated (left) and untreated (right) mouse long bones. Specific CXCL12 signal (red) was detected along endosteal surfaces (arrows) and within the bone marrow (arrowheads; n = 3-5, each group). (B) Transgenic (pOBCol2.3-GFP) mice expressing GFP in osteoblast lineage cells were treated with cytokines(n = 4-5 each group), and stromal cells were isolated and fractionated by flow cytometry into nonosteoblast and osteoblast (GFP+) fractions. Shown are representative dot plots showing the sorting strategy; data are gated on CD45 Ter119 stromal cells. (C) CXCL12 mRNA expression (relative to β-actin) in the GFP+ (osteoblast) cell fraction is shown. Data represent mean ± SEM; *P < .05.

Matthew J. Christopher, et al. Blood. 2009 August 13;114(7):1331-1339.
7.
Figure 5

Figure 5. From: Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization.

Disruption of CXCL12/CXCR4 signaling is a common feature in cytokine-induced mobilization. Wild-type mice (n = 6-8 each group) were left untreated (ctrl) or treated with G-CSF, Flt3L, or SCF for 7 days. Shown is the number of CFU-Cs in the blood (A) and bone marrow (B). (C) CXCR4 surface expression of Kit+ lineage cells in the blood (PB) and bone marrow (BM) was measured by flow cytometry. Shown is the mean fluorescent intensity (MFI). (D) The migration of CFU-Cs isolated from the blood or bone marrow in response to CXCL12 was measured using a transwell assay. Shown is the percentage of input CFU-Cs that migrated in response to CXCL12. (E) CXCL12 mRNA expression in the bone marrow (relative to β-actin) was measured by real-time RT-PCR. (F) CXCL12 protein expression in bone marrow plasma was measured by ELISA. Shown is the expression relative to control bone marrow. Data represent mean ± SEM; *P < .05; **P < .01.

Matthew J. Christopher, et al. Blood. 2009 August 13;114(7):1331-1339.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk